O-GlcNAcylation of UGDH: emerging insights into immunometabolic regulation and therapeutic implications

Read full text Summarise with VIRAT
Authors: Qiang Wu, Ting Lei, Shujing Wang
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lin B, Zhou J, Geng D, Chai S, Zhang X, Zhang Z, et al. O-GlcNAcylation of UGDH regulates its activity and remodels the extracellular matrix to facilitate tumor growth. Cell Death Differ. 2025. https://doi.org/10.1038/s41418-025-01591-8 . Google Scholar Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, et al. O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci USA. 2023;120:e2216796120. https://doi.org/10.1073/pnas.2216796120 . Google Scholar Zhan D, Yalcin F, Ma D, Fu Y, Wei S, Lal B, et al. Targeting UDP-α-d-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growth. Genes Dis. 2022;9:717–30. https://doi.org/10.1016/j.gendis.2021.08.008 . Google Scholar Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, et al. KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer. Cancer Cell. 2019;35:559–72.e557. https://doi.org/10.1016/j.ccell.2019.02.008 . Google Scholar Martinez-Ordoñez A, Duran A, Ruiz-Martinez M, Cid-Diaz T, Zhang X, Han Q, et al. Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer. Cancer Cell. 2023;41:252–71.e259. https://doi.org/10.1016/j.ccell.2022.11.016 . Google Scholar Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017–22. https://doi.org/10.1038/nature05815 . Google Scholar Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL, et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell. 2014;54:820–31. https://doi.org/10.1016/j.molcel.2014.04.026 . Google Scholar Cheng SS, Mody AC, Woo CM. Opportunities for therapeutic modulation of O-GlcNAc. Chem Rev. 2024;124:12918–3019. https://doi.org/10.1021/acs.chemrev.4c00417 . Google Scholar Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbæk MS, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer. 2019;7:68 https://doi.org/10.1186/s40425-019-0556-6 . Google Scholar Yin H, Zhu J. Methods for quantification of glycopeptides by liquid separation and mass spectrometry. Mass Spectrom Rev. 2023;42:887–917. https://doi.org/10.1002/mas.21771 . Google Scholar Stromnes IM, Schmitt TM, Hulbert A, Brockenbrough JS, Nguyen H, Cuevas C, et al. T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma. Cancer Cell. 2015;28:638–52. https://doi.org/10.1016/j.ccell.2015.09.022 . Google Scholar Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, et al. Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Cancer Cell. 2019;35:885–900. https://doi.org/10.1016/j.ccell.2019.05.004 . Google Scholar Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017;18:452–65. https://doi.org/10.1038/nrm.2017.22 . Google Scholar Sun K, Zhi Y, Ren W, Li S, Zheng J, Gao L, et al. Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance. Exp Hematol Oncol. 2024;13:107 https://doi.org/10.1186/s40164-024-00569-5 . Google Scholar Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, Bruggner RV, et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol. 2012;30:858–67. https://doi.org/10.1038/nbt.2317 . Google Scholar Download references

Fields of Study & Subjects

Glycosylation and Glycoproteins Research Cancer Immunotherapy and Biomarkers Proteoglycans and glycosaminoglycans research

Publication details

Journal / source
Cell Death Discovery
Volume
12
Issue
1
Pages
209
Publication date
31 March 2026
Language
EN